MedPath

Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea

Not Applicable
Withdrawn
Conditions
Gastroenteritis
Registration Number
NCT02080130
Lead Sponsor
Sinaloa Pediatric Hospital
Brief Summary

The purpose of this study is to determine which of two different preparations of probiotics is effective in the treatment of acute viral diarrhoea in children.

Detailed Description

Children and infants, aged 1 month to 5 years, with acute diarrhoea, will be randomised to receive either saccharomyces boulardii, a combination probiotic (Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus plantarum, Bifidobacterium infantis, Streptococcus thermophillus) or placebo, to determine if one shortens the duration of diarrhoea.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Clinical diagnosis of acute viral gastroenteritis
Exclusion Criteria
  • Moderate or severe dehydration
  • Malnutrition
  • Immunodeficiencies
  • Sepsis or bacterial infection
  • Previous use of antibiotics, antidiarrheal drugs, or probiotics, in the last four weeks.
  • Hospitalisation
  • No phone number
  • Illiteracy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Duration of diarrhoea in hoursUp to 7 days
Secondary Outcome Measures
NameTimeMethod
Percentage of children requiring hospitalisationUp to 7 days
Adverse effectsUp to 7 days
Number of liquid stoolsUp to seven days

Trial Locations

Locations (1)

Sinaloa Pediatric Hospital

πŸ‡²πŸ‡½

Culiacan, Sinaloa, Mexico

Sinaloa Pediatric Hospital
πŸ‡²πŸ‡½Culiacan, Sinaloa, Mexico

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.